MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Subthalamic Nucleus Oscillatory Coupling During Sleep is Impaired in Parkinson’s Disease and Associated with Memory Consolidation

    ZX. Yin, HL. Tan, JG. Zhang (Beijing, China)

    Objective: To investigate whether the subthalamic nucleus (STN) supports sleep-dependent memory consolidation through hierarchical oscillatory coupling, and whether this mechanism is disrupted in Parkinson's disease…
  • 2026 International Congress

    Long-term safety of deep brain stimulation (DBS): Real-world evidence

    J. Joseph, Y. Pathak, C. Salazar, A. Benison (Austin, USA)

    Objective: In this analysis, we aimed to evaluate long-term safety of DBS systems in real-world use. Background: Deep brain stimulation (DBS) is an established therapy for…
  • 2026 International Congress

    Temporal Interference Stimulation of Dentate Nucleus Suppressed Essential Tremor

    S. Zhang, W. Ren, D. Li, M. Zhou, Z. Zhou, X. Song, T. Ma, T. Xu, Z. Gao, Y. Wu (Shanghai, China)

    Objective: To assess the effect of 7-session transcranial temporal interference stimulation(tTIS) targeting dentate nucleus (DN) in people with essential tremor (ET). Background: ET is a…
  • 2026 International Congress

    Genetic spectrum of spinocerebellar ataxia type 27b (atx-fgf14-gaa): a single-center study

    A. Protsenko, N. Abramycheva, E. Nuzhnyi, S. Klyushnikov, S. Illarioshkin (Moscow, Russian Federation)

    Objective: To describe the genetic spectrum of (GAA)n-expansions in the FGF14 gene (size and structural repeats) associated with SCA27B in Slavic patients. Background: The genetic…
  • 2026 International Congress

    Analysis of Genetic Variants Associated with Parkinson’s Disease and Depression

    D. Delgado-Gutiérrez, E. Gaspar-Martínez, J. Esquivias-Farias, I. Espinosa-Méndez, E. Fernández-Toledo, A. Medina-Rivera, P. Reyes-Pérez (Querétaro, Mexico)

    Objective: The objective of this study was to evaluate the effect of SNPs in BDNF on depressive symptomatology in a sample of individuals with PD.…
  • 2026 International Congress

    Attention-Enhanced Deep Learning for Midbrain MRI Segmentation in Parkinson’s Disease

    C. Mahapatra, S. Swain (Powai, India)

    Objective: To develop an automated deep learning framework for robust midbrain segmentation in MRI data of Parkinson’s disease patients. Background: Structural alterations in the midbrain…
  • 2026 International Congress

    FUS R521S mutation causing levodopa responsive amyotrophic lateral sclerosis-Parkinson’s disease (ALS-PD).

    R. Peh, EK. Tan, P. Kumar, MH. Yong, K. Narasimhalu (Singapore, Singapore)

    Objective: The coexistence of Parkinson's disease (PD) and ALS is uncommon. This overlap syndrome, characterized by levodopa-responsive parkinsonism in the context of ALS, has been…
  • 2026 International Congress

    Clinical progression of PSP-Richardson’s syndrome and other PSP variants in an East Asian cohort

    SM. Lee, R. Kim, JY. Lee (Seoul, Republic of Korea)

    Objective: This study aimed to compare longitudinal clinical progression between patients with progressive supranuclear palsy–Richardson syndrome (PSP-RS) and those with PSP-subcortical phenotypes. Background: PSP is…
  • 2026 International Congress

    Automated Identification of Freezing of Gait in Parkinson’s Disease Using Q-Learning Analysis during Virtual Reality–Based Gait Task

    K. Seo, M. Hara, S. Alaoui, T. Yamamoto, G. Oyama (Saitama, Japan)

    Objective: To investigate whether a virtual reality (VR)-based gait task can induce freezing of gait (FOG) in Parkinson’s disease (PD) and whether gait trajectory data…
  • 2026 International Congress

    Exploring a Milestone-Based Approach as an Outcome Measure for Disease-Modifying Parkinson Disease Trials

    C. Gonzalez-Robles, M. Burnell, A. Schrag, R. Weil, G. Mills, ML. Zeissler, J. Carpenter, S. Gandhi, C. Carroll, T. Foltynie (London, United Kingdom)

    Objective: To replicate a composite milestone(CM) approach in a range of Parkinson Disease(PD) studies(observational, clinical trials) over a long time period(up to 12 years). To…
  • « Previous Page
  • 1
  • …
  • 92
  • 93
  • 94
  • 95
  • 96
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley